Navigation Links
Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008
Date:3/23/2009

MECHANICSBURG, Pa., March 23 /PRNewswire/ -- Select Medical Corporation ("Select") today announced results for its fourth quarter and year ended December 31, 2008.

For the fourth quarter ended December 31, 2008, net operating revenues increased 5.6% to $547.1 million compared to $518.0 million for the same quarter, prior year. Income from operations increased 37.9% to $57.5 million compared to $41.7 million for the same quarter, prior year. Net income increased 20.5% to $13.5 million compared to $11.2 million for the same quarter, prior year. Additionally, net income before interest, income taxes, depreciation and amortization, gain on early retirement of debt, stock compensation expense, other expense and minority interest ("Adjusted EBITDA") for the fourth quarter increased 32.1% to $76.5 million compared to $57.9 million for the same quarter, prior year. A reconciliation of net income to Adjusted EBITDA is attached to this release.

For the year ended December 31, 2008, net operating revenues increased 8.1% to $2,153.4 million compared to $1,991.7 million for the prior year. Income from operations increased 1.3% to $196.4 million compared to $193.9 million for the prior year. Net income decreased 21.3% to $43.4 million compared to $55.1 million for the prior year. Additionally, Adjusted EBITDA for the year ended December 31, 2008 increased 6.0% to $270.3 million compared to $254.9 million for the prior year.

Specialty Hospitals

At December 31, 2008, Select operated 88 long term acute care hospitals and five acute medical rehabilitation hospitals. This compares to 83 long term acute care hospitals and four acute medical rehabilitation hospitals operated at December 31, 2007. For the fourth quarter of 2008, net operating revenues for all of Select's hospitals increased 8.7% to $383.7 million compared to $352.9 million for the same quarter, prior year. Total patient days for t
'/>"/>

SOURCE Select Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
3. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
4. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
5. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
6. Mindray Selects Actel Low-Power Flash FPGAs for Demanding Medical Equipment Applications
7. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
8. Harvard Researchers Select S.C. BlueCross for National Honor
9. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
10. Fry Construction Selected for High-Profile Medical Imaging Project
11. Meth Project Advertisements Selected for National Prevention Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:The Logo Loft Hires Laid-Off Sales Executive Increasing Sales for Company by 15% Despite the Recession 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2Health News:Unanimous Vote Creates Largest RN Union in U.S. History 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5
Other Medicine News:Health News:Low-Income Women's Cancer Screenings Cost Effective: Report 2Health News:Low-Income Women's Cancer Screenings Cost Effective: Report 3Health News:Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab 2Health News:Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab 3Health News:Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab 4Health News:CSL Behring's Helixate(R) FS Now Available in 2000 IU Vial Size to Improve Patient Convenience, Encourage Compliance 2Health News:CSL Behring's Helixate(R) FS Now Available in 2000 IU Vial Size to Improve Patient Convenience, Encourage Compliance 3Health News:Ireland Cancer Center researcher finds standard treatment for breast cancer not followed 2Health News:Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America 2Health News:If You Are 50 and Over, Make Getting Screened for Colorectal Cancer Your New Year's Resolution 2Health News:If You Are 50 and Over, Make Getting Screened for Colorectal Cancer Your New Year's Resolution 3
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Looking to Shape Up for Summer 3F The Solution May Be the Steps Youre Already Taking 51603 1Looking to Shape Up for Summer 3F The Solution May Be the Steps Youre Already Taking 51603 2Looking to Shape Up for Summer 3F The Solution May Be the Steps Youre Already Taking 51603 3Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 1Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 2Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 3Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 4Brain Monitor Eliminates Need for Routine Oxygen With Propofol Friedberg 26apos 3Bs Triad Unveiled 13019 1Brain Monitor Eliminates Need for Routine Oxygen With Propofol Friedberg 26apos 3Bs Triad Unveiled 13019 2Brain Monitor Eliminates Need for Routine Oxygen With Propofol Friedberg 26apos 3Bs Triad Unveiled 13019 3Brain Monitor Eliminates Need for Routine Oxygen With Propofol Friedberg 26apos 3Bs Triad Unveiled 13019 4